As nicotine pouches continue to attract regulatory attention, a recurring challenge for policymakers is separating assumptions from evidence. Much of the debate has focused on hypothetical risks, youth narratives, or
Following GINN’s recent market‑insights visit to Lebanon, led by our Director Shem Baldeosingh, we continue to learn from frontline experts who see the realities of nicotine use, smoking, and harm
As nicotine pouches continue to expand across multiple markets, questions about who uses them, why they are used, and how they fit into tobacco control strategies are becoming increasingly important.
In recent months, Argentina has emerged as an unexpected focal point in the global debate over nicotine pouches, harm reduction, and regulatory coherence. As international brands begin to enter the
As regulators continue to assess the role of nicotine pouches within tobacco control frameworks, evidence on how these products are actually used over time remains limited. A recently published prospective
Across Europe, policymakers continue to express concern that fragmented nicotine regulation is leaving young people exposed to risk. Recent commentary has pointed to uneven national rules governing nicotine pouches, vapes,
A GINN response to “The war on snus” The Cyprus Mail article “The war on snus” highlights a regulatory paradox that is becoming increasingly familiar across Europe: nicotine pouches are
Executive context Innovation in nicotine pouches has largely focused on formulation variables, nicotine strength, pH, buffering systems, flavours, and moisture content. These factors shape nicotine delivery and user perception and
Regulation, clinical context, and evidence-based harm reduction Cigarette smoking continues to impose a disproportionate health burden in Appalachia, a region marked by persistently high smoking prevalence, elevated rates of cardiovascular
A Deep Dive into the Future of Novel NicotineWe wish to share the latest episode of the Tobacco Asia / InterTabac podcast, where GINN’s Director Shem Baldeosingh joins Thomas Schmid
Recent analysis published in The Lancet Public Health reinforces a long-standing but often overlooked reality in tobacco control: nicotine use is not a monolith, and public-health outcomes depend critically on
Nicotine pouch performance is often discussed almost exclusively in terms of formulation. Nicotine concentration, pH, buffering systems, flavour chemistry, and moisture balance dominate both technical development and regulatory review. These